Yawei Shi

611 total citations
26 papers, 457 citations indexed

About

Yawei Shi is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yawei Shi has authored 26 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Yawei Shi's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Autophagy in Disease and Therapy (3 papers). Yawei Shi is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and Autophagy in Disease and Therapy (3 papers). Yawei Shi collaborates with scholars based in China, United States and Switzerland. Yawei Shi's co-authors include Nan Shao, Ying Lin, Yunjian Zhang, Runyi Ye, Shenming Wang, Yang Zhao, Zeng Fang, Weibin Wu, Jin Zhang and Minghan Jia and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Yawei Shi

26 papers receiving 452 citations

Peers

Yawei Shi
Weiwei Shen China
Cheng Tang China
Peide Bai China
Hui Wen China
Claudia Esposito Italy
Honghe Luo China
Jizhun Zhang China
Shichong Liao China
Yong Cheng China
Boxing Su China
Weiwei Shen China
Yawei Shi
Citations per year, relative to Yawei Shi Yawei Shi (= 1×) peers Weiwei Shen

Countries citing papers authored by Yawei Shi

Since Specialization
Citations

This map shows the geographic impact of Yawei Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yawei Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yawei Shi more than expected).

Fields of papers citing papers by Yawei Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yawei Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yawei Shi. The network helps show where Yawei Shi may publish in the future.

Co-authorship network of co-authors of Yawei Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yawei Shi. A scholar is included among the top collaborators of Yawei Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yawei Shi. Yawei Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Shu‐Mei, Dongni Shi, Shuqin Dai, et al.. (2025). RNF31 induces paclitaxel resistance by sustaining ALYREF cytoplasmic–nuclear shuttling in human triple‐negative breast cancer. Clinical and Translational Medicine. 15(2). e70203–e70203. 4 indexed citations
2.
Zhang, Mengmeng, Ting Liu, Yubin Xie, et al.. (2024). Genomic and transcriptomic profiling of inflammatory breast cancer reveals distinct molecular characteristics to non-inflammatory breast cancers. Breast Cancer Research and Treatment. 208(2). 441–459. 2 indexed citations
3.
Stevens, Laura E., Filipa Lynce, Wendy Y. Chen, et al.. (2024). A Subpopulation of Luminal Progenitors Secretes Pleiotrophin to Promote Angiogenesis and Metastasis in Inflammatory Breast Cancer. Cancer Research. 84(11). 1781–1798. 8 indexed citations
4.
Su, Xiujuan, Yawei Shi, Lei Shi, et al.. (2024). Association between adenomyosis volume and adverse perinatal outcomes: multicenter cohort study. Ultrasound in Obstetrics and Gynecology. 64(5). 678–686. 2 indexed citations
5.
Liu, Sihua, et al.. (2024). Patterns of Recurrence and Survival Outcomes of HER2-Low Expression in Early-Stage Breast Cancer. Clinical Breast Cancer. 25(3). 242–250.e6. 3 indexed citations
6.
Shao, Nan, et al.. (2023). Effect of Lipid Levels on Tumor-Infiltrating Lymphocytes and Prognosis in Patients with Triple-Negative Breast Cancer. Breast Care. 18(5). 390–398. 1 indexed citations
7.
Zhao, Yang, et al.. (2022). DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer. Molecular Biology Reports. 49(5). 3939–3947. 11 indexed citations
8.
Jian, Yunting, Hongyi Xu, Yawei Shi, et al.. (2022). Protein phosphatase 1 regulatory inhibitor subunit 14C promotes triple‐negative breast cancer progression via sustaining inactive glycogen synthase kinase 3 beta. Clinical and Translational Medicine. 12(1). e725–e725. 14 indexed citations
9.
Ye, Runyi, Dongwei Liu, Hongyu Guan, et al.. (2021). AHNAK2 promotes thyroid carcinoma progression by activating the NF-κB pathway. Life Sciences. 286. 120032–120032. 16 indexed citations
10.
11.
Shao, Nan, Chuanbo Xie, Yawei Shi, et al.. (2019). <p>Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis</p>. Cancer Management and Research. Volume 11. 1433–1442. 36 indexed citations
12.
Yu, Liang, Chunyang Wang, Fu‐shun Pan, et al.. (2019). HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling. Biomedicine & Pharmacotherapy. 118. 109361–109361. 10 indexed citations
13.
Shao, Nan, Yawei Shi, Liang Yu, et al.. (2019). Prospect for Application of PARP Inhibitor in Patients with HER2 Negative Breast Cancer. International Journal of Biological Sciences. 15(5). 962–972. 14 indexed citations
14.
Shi, Yawei, Yang Zhao, Yunjian Zhang, et al.. (2018). AFF3 upregulation mediates tamoxifen resistance in breast cancers. Journal of Experimental & Clinical Cancer Research. 37(1). 254–254. 27 indexed citations
15.
Shi, Yawei, Yang Zhao, Yunjian Zhang, et al.. (2018). TNNT1 facilitates proliferation of breast cancer cells by promoting G1/S phase transition. Life Sciences. 208. 161–166. 33 indexed citations
16.
Shi, Yawei, Yang Zhao, Nan Shao, et al.. (2017). Overexpression of microRNA-96-5p inhibits autophagy and apoptosis and enhances the proliferation, migration and invasiveness of human breast cancer cells. Oncology Letters. 13(6). 4402–4412. 49 indexed citations
17.
Zhou, Yu, Nan Shao, Jin Zhang, et al.. (2017). High PD-L1 Expression Is Closely Associated With Tumor-Infiltrating Lymphocytes and Leads to Good Clinical Outcomes in Chinese Triple Negative Breast Cancer Patients. International Journal of Biological Sciences. 13(9). 1172–1179. 51 indexed citations
18.
19.
Xu, Gang, Li Zhu, Yan Wang, et al.. (2017). Stattic Enhances Radiosensitivity and Reduces Radio-Induced Migration and Invasion in HCC Cell Lines through an Apoptosis Pathway. BioMed Research International. 2017. 1–9. 25 indexed citations
20.
Shi, Yawei, et al.. (1994). [Effect of hypoxia on the growth and differentiation of NG108-15 cells].. PubMed. 46(3). 244–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiwei Shen Breakdown of academic impact, for papers by Cheng Tang Breakdown of academic impact, for papers by Peide Bai Breakdown of academic impact, for papers by Hui Wen Breakdown of academic impact, for papers by Claudia Esposito Breakdown of academic impact, for papers by Honghe Luo Breakdown of academic impact, for papers by Jizhun Zhang Breakdown of academic impact, for papers by Shichong Liao Breakdown of academic impact, for papers by Yong Cheng Breakdown of academic impact, for papers by Boxing Su
Rankless by CCL
2026